Healthcare provider profile · identity verified

Eva Patton Tackett, MD

Internal Medicine · HUNTINGTON, WV · NPI 1245445188

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	153	48
Losartan Potassium	Losartan Potassium	135	36
Levothyroxine Sodium	Levothyroxine Sodium	115	35
Lisinopril	Lisinopril	109	33
Omeprazole	Omeprazole	105	34
Gabapentin	Gabapentin	91	21
Metoprolol Succinate	Metoprolol Succinate	83	25
Mirtazapine	Mirtazapine	78	16
Ozempic	Semaglutide	78	suppressed
Famotidine	Famotidine	77	19
Amlodipine Besylate	Amlodipine Besylate	73	26
Eliquis	Apixaban	71	18
Jardiance	Empagliflozin	71	19
Albuterol Sulfate Hfa	Albuterol Sulfate	70	16
Duloxetine Hcl	Duloxetine Hcl	67	17
Pravastatin Sodium	Pravastatin Sodium	65	19
Trazodone Hcl	Trazodone Hcl	61	14
Furosemide	Furosemide	60	21
Tramadol Hcl	Tramadol Hcl	57	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	21
Venlafaxine Hcl Er	Venlafaxine Hcl	49	13
Montelukast Sodium	Montelukast Sodium	46	14
Spironolactone	Spironolactone	46	13
Tamsulosin Hcl	Tamsulosin Hcl	46	15
Metformin Hcl Er	Metformin Hcl	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Simvastatin	Simvastatin	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	32	11
Metformin Hcl	Metformin Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Carvedilol	Carvedilol	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Prednisone	Prednisone	23	13
Naproxen	Naproxen	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Baclofen	Baclofen	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Dofetilide	Dofetilide	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Finasteride	Finasteride	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error